Intellia Therapeutics (NTLA) FCF Margin Growth (3y) (2018 - 2026)
Intellia Therapeutics (NTLA) FCF Margin Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
10,029.00 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
723.00 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Intellia Therapeutics |
1.60 Bn |
1.60 Bn |
- |
11,733.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
11,733.00 |
| Dec 31, 2025 |
38,978.00 |
| Sep 30, 2025 |
6,591.00 |
| Jun 30, 2025 |
-8,025.00 |
| Mar 31, 2025 |
-15,392.00 |
| Dec 31, 2024 |
-18,150.00 |
| Sep 30, 2024 |
2.22 Mn |
| Jun 30, 2024 |
6,738.00 |
| Mar 31, 2024 |
40,097.00 |
| Dec 31, 2023 |
544,645.00 |
| Sep 30, 2023 |
-65,234.00 |
| Jun 30, 2023 |
-105,166.00 |
| Mar 31, 2023 |
-10,987.00 |
| Dec 31, 2022 |
-40,533.00 |
| Sep 30, 2022 |
-35,256.00 |
| Jun 30, 2022 |
-36,580.00 |
| Mar 31, 2022 |
-53,238.00 |
| Dec 31, 2021 |
-38,602.00 |
| Sep 30, 2021 |
-2.30 Mn |
| Jun 30, 2021 |
-58,942.00 |
